Caliber Associates Recruits CHRO for INOVIO Pharmaceuticals
July 23, 2021 – San Diego, CA- based Caliber Associates recently placed former Allergan executive, Asli Gevgilili, as the new chief human resource officer (CHRO) of INOVIO Pharmaceuticals. Steve Hochberg, CEO and founder of Caliber Associates, led the assignment.
“We believe Asli’s depth of expertise and experience will provide important focus to INOVIO’s growth strategy,” Mr. Hochberg said. Ms. Gevgilili brings extensive global experience in human resources strategy, team leadership, executive development, organization development and culture, talent capability building and reward recognition programs within life sciences. Most recently, she served as vice president of human resources for Allergan PLC/ Abbvie.
Executive Recruiters & Talent Leaders
Reveal Market Forecast
The pandemic caused an unprecedented disruption to executive search activity in 2020. Executive recruiters spent the better part of last year resetting expectations in the midst of an unprecedented interruption to their business. But according to recruiting industry leaders interviewed for this report, the search business is turning a significant corner.
We take a critical look back, examine search firm performance, and uncover fresh market opportunities. Leading executive recruiters offer up their viewpoints, and forecasts, for 2021. The good news: optimism reigns. And that means we could be in for one of the biggest growth spurts the executive search sector has enjoyed in years. Here’s our latest thinking. A special thanks to our co-sponsor: N2Growth! Buy your copy today!
INOVIO Pharmaceuticals is a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer. INOVIO has 15 DNA medicine clinical programs currently in development focused on HPV-associated diseases, cancer, and infectious diseases, including coronaviruses associated with COVID-19 and MERS, for which programs are being developed with funding support from the U.S. Department of Defense and the Coalition for Epidemic Preparedness Innovations (CEPI).
Life Sciences Recruiters
Caliber Associates, founded in 1988, is focused exclusively on the life sciences sector. The firm’s leaders are highly experienced search professionals and biopharmaceutical executives who bring more than 70 years of industry experience. Caliber Associates has partnered with over 150 leading companies and has completed upwards of 700 searches, placing strategic leaders with broad therapeutic and functional reach. The firm has offices in San Diego, metro New York and Boston/Cambridge, MA.
Caliber Associates Recruits Chief Medical Officer for NextCure
Recently, numerous healthcare organizations have turned to executive search firms to find new chief medical officers. In the era of COVID-19 this is likely to be another burgeoning area for executive search firms.
Caliber Associates placed former NexImmune executive Han Myint as the new chief medical officer for NextCure, a clinical-stage biopharmaceutical company. Steve Hochberg, CEO and founder of Caliber Associates, led the assignment. “We are very excited that Han has joined the NextCure team,” said Michael Richman, president and CEO of NextCure. “We believe the depth of his expertise in oncology product development will prove instrumental in the advancement of our product pipeline. Han’s strong industry track record is highlighted by his involvement in the development of multiple U.S. Food and Drug approved products.”
Among the roles that the firm has recently filled include chief scientific officer for GentiBio, vice president of project management at Locanabio and CEO for Caraway Therapeutics.
Mr. Hochberg focuses on recruiting CEOs, board members, C-level and strategic teams for emerging life science companies and global biopharmaceutical companies. He has assembled a small team of highly experienced, results driven search professionals. Prior to his search career, he held strategic human resources roles with Rhône-Poulenc Rorer, FMC Corp., and Shell Oil Co.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media